168 related articles for article (PubMed ID: 37487542)
1. The role of the immune system in cutaneous T-cell lymphoma; an area requiring more investigation.
Pileri A; Pimpinelli N
Br J Dermatol; 2023 Oct; 189(5):504-505. PubMed ID: 37487542
[No Abstract] [Full Text] [Related]
2. The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
Br J Dermatol; 2023 Oct; 189(5):e97. PubMed ID: 37879744
[No Abstract] [Full Text] [Related]
3. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
Dippel E; Schrag H; Goerdt S; Orfanos CE
Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
[No Abstract] [Full Text] [Related]
5. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
[No Abstract] [Full Text] [Related]
6. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.
Suchin KR; Cucchiara AJ; Gottleib SL; Wolfe JT; DeNardo BJ; Macey WH; Bromley PG; Vittorio CC; Rook AH
Arch Dermatol; 2002 Aug; 138(8):1054-60. PubMed ID: 12164743
[TBL] [Abstract][Full Text] [Related]
9. CD209
Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
[TBL] [Abstract][Full Text] [Related]
10. Photopheresis therapy for cutaneous T-cell lymphoma.
Duvic M; Hester JP; Lemak NA
J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
[TBL] [Abstract][Full Text] [Related]
11. Photopheresis for cutaneous T cell lymphoma.
Heald PW
Ann N Y Acad Sci; 1991 Dec; 636():171-7. PubMed ID: 1793207
[No Abstract] [Full Text] [Related]
12. Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis.
Haley HR; Davis DA; Sams WM
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):880-3. PubMed ID: 10534677
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
Rook AH; Gottlieb SL; Wolfe JT; Vowels BR; Sood SS; Niu Z; Lessin SR; Fox FE
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():16-20. PubMed ID: 9020930
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
[No Abstract] [Full Text] [Related]
17. Metastasizing squamous cell carcinomas in a patient treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
Hoetzenecker W; Benedix F; Woelbing F; Yazdi A; Breuninger H; Röcken M; Berneburg M
Acta Derm Venereol; 2007; 87(5):445-6. PubMed ID: 17721661
[No Abstract] [Full Text] [Related]
18. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis.
Gmyrek R; Beer R; Elizeri Y; Oster MW; Silvers DN; Schneiderman P; Grossman ME
Cutis; 1999 Oct; 64(4):261-4. PubMed ID: 10544882
[TBL] [Abstract][Full Text] [Related]
19. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
Akilov OE
Cells; 2023 Sep; 12(18):. PubMed ID: 37759543
[TBL] [Abstract][Full Text] [Related]
20. Management of cutaneous T-cell lymphomas: Established and emergent therapies.
Wain T; Venning VL; Consuegra G; Fernandez-Peñas P; Wells J
Australas J Dermatol; 2019 Aug; 60(3):200-208. PubMed ID: 30809800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]